Cargando…
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma
Recent evidence demonstrates that the efficacy of conventional anticancer therapies including chemotherapy requires a functional immune system. Here, we addressed the possibility that the antitumor effect of a selective Smoothened antagonist and Hedgehog (Hh) pathway inhibitor (LDE225), a promising...
Autores principales: | Paget, Christophe, Duret, Helene, Ngiow, Shin Foong, Kansara, Maya, Thomas, David M., Smyth, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518504/ https://www.ncbi.nlm.nih.gov/pubmed/23243595 http://dx.doi.org/10.4161/onci.21680 |
Ejemplares similares
-
The interaction between murine melanoma and the immune system reveals that prolonged responses predispose for autoimmunity
por: Ngiow, Shin Foong, et al.
Publicado: (2013) -
BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013) -
Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
por: Ngiow, Shin Foong, et al.
Publicado: (2020) -
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
por: Vaghjiani, Vijesh G., et al.
Publicado: (2023) -
Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
por: Ram Kumar, Ram Mohan, et al.
Publicado: (2015)